ZyVersa Therapeutics Receives European Patent for VAR 200
Shares of ZyVersa Therapeutics saw a 9.2% increase in trading today following the announcement that the company has been granted a patent for its kidney disease treatment, VAR 200, by…
Shares of ZyVersa Therapeutics saw a 9.2% increase in trading today following the announcement that the company has been granted a patent for its kidney disease treatment, VAR 200, by…